trial · primary record
Daraxonrasib
Pancreatic Ductal Adenocarcinoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2029-08-13 |
| Primary endpoint | Successful Receipt of Surgery Rate |
| Registry ID | NCT07898813 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:42.885Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07898813
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.